A. Scettri et al.
136.1, 134.9, 129.7, 129.3, 107.5, 96.2, 90.1, 40.9, 37.2, 1378 cm-1 ; 1H NMR (400 MHz, CDCl3): 7.36 (d, 1 H, J =
25.8, 25.0 ppm. Anal. Calcd for C15H16ClNO5: C, 55.31; 1.88 Hz), 6.30 (dd, 1 H, J = 3.2, 1.88 Hz), 6.18 (d, 1 H,
H, 4.95; N, 4.30. Found C, 55.42; H, 4.83; N, 4.42.
J = 3.2 Hz), 5.19 (s, 1 H), 4.65 (dd, 1 H, J = 12.5, 7.5),
2,2-dimethyl-6-(3-nitro-2-p-tolylpropyl)-4H-1,3- 4.58 (dd, 1 H9, J = 12.5, 6.9); 4.01-3.94 ( m, 1 H), 2.72
dioxin-4-one 3c : Yellow oil. MS: m/z 306 [M+H+], (dd, 1 H, J = 14.5, 9.04 Hz), 2.65 (dd, 1 H, J = 14.5,
328 [M+Na+]; IR (KBr neat): 1726, 1636, 1555, 1378; 5.96 Hz), 1.66 (s, 3 H), 1.57 (s, 3 H) ppm. 13C NMR
1H NMR (400 MHz, CDCl3): 7.12 (d, 2 H, J = 8.0 Hz), (100 MHz, CDCl3): 167.3, 161.0, 150.7, 143.4, 110.5,
5.11 ( s, 1 H), 4.55 (d, 2 H, J = 7.6 Hz), 3.80-3.76 (m, 108.7, 96.1, 35.5, 30.8, 25.1, 23.4 ppm. Anal. Calcd for
1 H), 2.68 (dd, 1 H, J = 14.6, 6.0 Hz), 2.62 ( dd, 1 H, J = C13H15NO6: C, 55.51; H, 5.38; N, 4.98. Found C, 55.64;
14.6, 9.6 Hz), 2.30 (s, 3 H), 1.59 (s, 3 H), 1.44 (s, 3 H) H, 5.50; N, 5.10
ppm. 13C NMR (100 MHz, CDCl3): 167.9, 161.5, 138.7,
6-(2-cyclohexyl-3-nitropropyl)-2,2-dimethyl-4H-
134.4, 130.4, 127.8, 107.4, 96.0, 80.6, 41.2, 37.3, 25.9, 1,3-dioxin-4-one 3h :Yellow oil. MS: m/z [M+Na+];
24.9, 21.6 ppm. Anal. Calcd for C16H19NO5: C, 62.94; H, IR (KBr neat): 1730, 1636, 1553, 1377 cm-1; H NMR
1
6.27; N, 4.59. Found C, 62.82; H, 6.14; N, 4.46.
(400 MHz, CDCl3): 5.29 (s, 1 H), 4.44 (dd, 1 H, J = 12.5,
4-(3-(2,2-dimethyl-6-oxo-6H-1,3-dioxin-4-yl)-1- 6.2 Hz), 4.29 (dd, 1 H, J = 12.5, 7.0 Hz), 2.51-2.41 (m,
nitropropan-2-yl)benzonitrile 3d :Yellow oil. MS: m/z 3 H), 2.23 (dd, 1 H, J = 14.1, 7.3 Hz), 1.69 (s, 6 H),
317 [M+H+], 339 [M+Na+]; IR (KBr neat): 2230, 1725, 1.25-0.89 (m, 11 H) ppm. 13C NMR (100 MHz, CDCl3):
1555, 1378 cm-1; 1H NMR (400 MHz, CDCl3): 7.67 (d, 1 169.2, 161.1, 125.3, 107.3, 95.7, 40.5, 39.5, 33.9, 30.2,
H, J = 8.5 Hz), 7.34 (d, 1 H, J = 8.5 Hz), 5.17 (s, 1 H), 30.0, 29.7, 26.7, 26.4, 25.6, 25.5 ppm. Anal. Calcd for
4.67-4.57 (m, 2 H), 3.95-3.88 (m, 1 H), 2.75 (dd, 1 H, C15H13NO5: C, 60.59; H, 7.80; N, 4.71. Found C, 60.47;
J = 14.7, 6.4 Hz), 2.65 (dd, 1 H, J = 14.7, 9.1 Hz), 1.62 H, 7.69; N, 4.83.
(s, 3 H), 1.49 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3):
166.7, 160.7, 143.0, 133.5, 128.9, 118.5, 113.2, 107.6, data of compounds 5a-d and 5f-l see [30].
For general procedure, analytical and spectroscopic
96.4, 79.5, 41.4, 37.1, 25.7, 25.2 ppm. Anal. Calcd for
5-(1-nitroundecan-2-yl)furan-2(5H)-one 5e : 284
C16H16N2O5: C, 60.75; H, 5.10; N, 8.86. Found C, 60.61; (M+H+), 306 (M+Na+). IR (KBr, neat)1755, 1641, 1554,
H, 5.22;N, 8.72.
1382 cm-1. 1H NMR (400 MHz, CDCl3): 7.51-7.41 (m,
6-(2-(4-methoxyphenyl)-3-nitropropyl)-2,2- 1 Hanti + 1Hsyn), 6.26, (dd, 1 Hsyn, J = 5.7, 2.1), 6.18 (dd,
dimethyl-4H-1,3-dioxin-4-one 3e : Yellow oil. MS: m/z 1 Hanti, J = 5.7, 2.1), 5.20-5.16 (m, 1 Hanti + 1Hsyn), 4.52
344 [M+Na+]; IR (KBr neat): 1723, 1634, 1555, 1378, ((dd, 1Hanti, J = 13.4, 7.9), 4.39 (dd, 1 Hsyn, J = 13.4,
1
1016; H NMR (400 MHz, CDCl3): 7.09 8d, 1 H, J = 5.4), 4.35-4.30 (m, 1 Hanti + 1Hsyn), 2.65-2-40 (m, 1 Hanti
+
8.1 Hz), 6.85 (d, 1 H, J = 8.1 Hz), 5.12 (s, 1 H), 4.55-4.53 1Hsyn), 1.65-1.29 (m, 16 H), 0.85-0.90 (m, 3H). 13C NMR,
(m, 1 H), 3.80-3.73 (m, 4 H), 2.68 (dd, 1 H, J = 14.6, (100 MHz, CDCl3): 172.9, 154.4, 154.0, 124.0, 123.6,
5.9 Hz), 2.60 (dd, 1 H, J = 14.6, 9.7 Hz), 1.59 (s, 3 H), 83.0, 76.1, 74.7,40.5, 40.6, 40.3, 32.0, 29.7, 29.4, 27.5,
1.44 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): 168.0, 27.1, 26.8, 26.5, 25.9, 23.1,14.8 ppm. Anal. Calcd for
161.0, 130.0, 128.9, 115.1, 107.0, 96.1, 80.7, 55.8, 40.9, C15H25NO4,C, 63.58; H, 8.89; N, 4.94; Found C, 63.48;
37.4, 30.2, 25.9, 25.0 ppm. Anal. Calcd for C16H19NO6: H, 8.95 N, 4.87
C, 59.81; H, 5.96; N, 4.36. Found C, 59.78; H, 5.83; N,
4.25.
2,2-dimethyl-6-(3-nitro-2-(thiophen-2-yl)propyl)-
3. Results and discussion
4H-1,3-dioxin-4-one 3f : Yellow-orange oil. MS: m/z
344 [M+Na+]; IR (KBr neat): 1725, 1636, 1555, 1378;
Preliminarly, β-nitrostyrene 2a (R=Ph) was chosen as
the representative substrate, and, as is in our habit,
1H NMR (400 MHz, CDCl3): 7.25 (d, 1 H, J = 5.0 Hz),
6.94 (dd, 1 H, J = 5.04, 3.5 Hz), 6.90 (d, 1 H, J =
3.5 Hz), 5.20 (s, 1 H), 4.59 (d, 2 H, J = 7.2 Hz), 4.21-
4.12 (m, 1 H), 2.76 (dd, 1 H, J = 14.7, 5.7 Hz), 2.67
(dd, 1 H, J = 14.7, 9.5 Hz), 1.64 (s, 3 H), 1.51 (s, 3H)
ppm. 13C NMR (100 MHz, CDCl3): 167.3, 140.3, 129.7,
126.6, 125.9, 116.4, 107.5, 96.4, 80.6, 38.4, 30.1, 25.9,
24.9 ppm. Anal. Calcd for C13H15NO5S: C, 52.51; H,
5.09; N, 4.71. Found C, 52.39; H, 5.21;N, 4.83.
a control experiment was carried out in absence of any
catalyst under solvent-free conditions. The combination
of the nucleophilic/electrophilic properties of the
reagents 1 and 2a proved to be particularly successful
since the formation of the Michael γ-vinylogous adduct
3a occurred in good yield, complete selectivity and
rather reduced reaction time (Table 1, entry 1).
Furthermore, we were delighted to observe
a rather satisfactory level of general validity, since the
conjugate addition was found to take place under the
same conditions as in entry 1 (Table 1) with complete
6-(2-(furan-2-yl)-3-nitropropyl)-2,2-dimethyl-4H-
1,3-dioxin-4-one 3g :Yellow orange oil. MS: m/z 282
[M+H+], 304 [M+Na+]; IR (KBr neat): 1726, 1637, 1556,
49